
---
title: '恒瑞医药：药品环磷酰胺胶囊拟纳入优先审评程序'
categories: 
 - 金融
 - 证券时报网
 - 快讯
headimg: 'https://picsum.photos/400/300?random=4174'
author: 证券时报网
comments: false
date: Thu, 14 Oct 2021 15:46:00 GMT
thumbnail: 'https://picsum.photos/400/300?random=4174'
---

<div>   
<p>证券时报e公司讯，<a class="trsHotWords" href="http://info.stcn.com/dc/stock/?stockcode=SS600276" style="color: #2f67d1;text-decoration: none;" code="600276" target="_blank">恒瑞医药</a>(600276)10月14日晚间公告，公司药品环磷酰胺胶囊拟纳入优先审评程序；HRS7415片获得药物临床试验批准通知书。</p>

                  
</div>
            